Evidence map›Paper›PMID 38940448›Full record

ArticleJournal of medical virology2024

Dispersal history of SARS-CoV-2 in Galicia, Spain.

Pilar Gallego-García, Nuria Estévez-Gómez, Loretta De Chiara, Pilar Alvariño, Pedro M Juiz-González, Isabel Torres-Beceiro, Margarita Poza, Juan A Vallejo, Soraya Rumbo-Feal, Kelly Conde-Pérez and 41 more

Abstract read
In one paragraph

Article in Journal of medical virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

51 authors.

Pilar Gallego-GarcíaCINBIO, Universidade de Vigo, Vigo, Spain.
Nuria Estévez-GómezCINBIO, Universidade de Vigo, Vigo, Spain.
Loretta De ChiaraCINBIO, Universidade de Vigo, Vigo, Spain.
Pilar AlvariñoCINBIO, Universidade de Vigo, Vigo, Spain.
Pedro M Juiz-GonzálezServicio de Microbiología del Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
Isabel Torres-BeceiroServicio de Microbiología del Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
Margarita PozaMicrobiology Research Group, Institute of Biomedical Research (INIBIC) - Interdisciplinary Center for Chemistry and Biology (CICA), University of A Coruña (UDC) - CIBER de Enfermedades Infecciosas (CIBERINFEC-ISCIII), Edificio Sur, Hospital Universitario A Coruña, As Xubias, A Coruña, Spain.
Juan A VallejoMicrobiology Research Group, Institute of Biomedical Research (INIBIC) - Interdisciplinary Center for Chemistry and Biology (CICA), University of A Coruña (UDC) - CIBER de Enfermedades Infecciosas (CIBERINFEC-ISCIII), Edificio Sur, Hospital Universitario A Coruña, As Xubias, A Coruña, Spain.
Soraya Rumbo-FealMicrobiology Research Group, Institute of Biomedical Research (INIBIC) - Interdisciplinary Center for Chemistry and Biology (CICA), University of A Coruña (UDC) - CIBER de Enfermedades Infecciosas (CIBERINFEC-ISCIII), Edificio Sur, Hospital Universitario A Coruña, As Xubias, A Coruña, Spain.
Kelly Conde-PérezMicrobiology Research Group, Institute of Biomedical Research (INIBIC) - Interdisciplinary Center for Chemistry and Biology (CICA), University of A Coruña (UDC) - CIBER de Enfermedades Infecciosas (CIBERINFEC-ISCIII), Edificio Sur, Hospital Universitario A Coruña, As Xubias, A Coruña, Spain.
Pablo Aja-MacayaMicrobiology Research Group, Institute of Biomedical Research (INIBIC) - Interdisciplinary Center for Chemistry and Biology (CICA), University of A Coruña (UDC) - CIBER de Enfermedades Infecciosas (CIBERINFEC-ISCIII), Edificio Sur, Hospital Universitario A Coruña, As Xubias, A Coruña, Spain.
Susana LadraDatabase Laboratory, Research Center for Information and Communication Technologies (CITIC), University of A Coruña (UDC), A Coruña, Spain.
Antonio Moreno-FloresServicio de Microbiología, Hospital Universitario Lucus Augusti, Lugo, Spain.
María J Gude-GonzálezServicio de Microbiología, Hospital Universitario Lucus Augusti, Lugo, Spain.
Amparo CoiraDepartment of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela. SERGAS - Microbiology Research Group, Institute of Biomedical Research (IDIS), Santiago de Compostela, Spain.
Antonio AguileraDepartment of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela. SERGAS - Microbiology Research Group, Institute of Biomedical Research (IDIS), Santiago de Compostela, Spain.
José J Costa-AlcaldeDepartment of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela. SERGAS - Microbiology Research Group, Institute of Biomedical Research (IDIS), Santiago de Compostela, Spain.
Rocío TrastoyDepartment of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela. SERGAS - Microbiology Research Group, Institute of Biomedical Research (IDIS), Santiago de Compostela, Spain.
Gema Barbeito-CastiñeirasDepartment of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela. SERGAS - Microbiology Research Group, Institute of Biomedical Research (IDIS), Santiago de Compostela, Spain.
Daniel García-SoutoCiMUS, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
José M C TubioCiMUS, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Matilde Trigo-DaportaClinical Microbiology Unit, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
Pablo Camacho-ZamoraClinical Microbiology Unit, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
Juan García CostaServicio de Microbiología, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
María González-DomínguezServicio de Microbiología, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
Luis Canoura-FernándezServicio de Microbiología, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
Daniel Glez-PeñaCINBIO, Universidade de Vigo, Vigo, Spain.
Sonia Pérez-CastroDepartment of Microbiology, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Jorge J CabreraDepartment of Microbiology, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Carlos Daviña-NúñezMicrobiology and Infectology Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Montserrat Godoy-DizDepartment of Microbiology, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Ana Belén Treinta-ÁlvarezDepartment of Microbiology, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
Maria Isabel VeigaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
João Carlos SousaLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Nuno S OsórioLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Iñaki ComasTuberculosis Genomics Unit, BioMedicine Institute of Valencia, Spanish Research Council (CSIC), Valencia, Spain.
Fernando González-CandelasCIBER in Epidemiology and Public Health, Madrid, Spain.ORCID 0000-0002-0879-5798
Samuel L HongDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Epidemiological Virology, KU Leuven, University of Leuven, Leuven, Belgium.
Nena BollenDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Epidemiological Virology, KU Leuven, University of Leuven, Leuven, Belgium.
Simon DellicourDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Epidemiological Virology, KU Leuven, University of Leuven, Leuven, Belgium.
Guy BaeleDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Epidemiological Virology, KU Leuven, University of Leuven, Leuven, Belgium.
Marc A SuchardDepartment of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Epidemiological Virology, KU Leuven, University of Leuven, Leuven, Belgium.
Andrés AgullaServicio de Microbiología del Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
Germán BouMicrobiology Research Group, Institute of Biomedical Research (INIBIC) - Interdisciplinary Center for Chemistry and Biology (CICA), University of A Coruña (UDC) - CIBER de Enfermedades Infecciosas (CIBERINFEC-ISCIII), Edificio Sur, Hospital Universitario A Coruña, As Xubias, A Coruña, Spain.
Pilar Alonso-GarcíaServicio de Microbiología, Hospital Universitario Lucus Augusti, Lugo, Spain.
María Luisa Pérez-Del-MolinoDepartment of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela. SERGAS - Microbiology Research Group, Institute of Biomedical Research (IDIS), Santiago de Compostela, Spain.
Marta García-CampelloClinical Microbiology Unit, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
Isabel Paz-VidalServicio de Microbiología, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.
Benito RegueiroDepartment of Microbiology, Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, Spain.
David PosadaCINBIO, Universidade de Vigo, Vigo, Spain.ORCID 0000-0003-1407-3406

Funding

Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Laura D. Hughes · 2018 to 2026
$32.0M
Fast and flexible Bayesian phylogenetics via modern machine learningR01AI162611 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2021 to 2025
$3.8M
Statistical Innovation to Integrate Sequences and Phenotypes for Scalable Phylodynamic InferenceR01AI153044 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Marc A. Suchard · 2021 to 2026
$2.4M
Banco Santander-CSIC-CRUE EPICOVIGAL FONDO SUPERA-COVID19Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de GaliciaConsellería de Sanidade, Xunta de GaliciaDURABLE EU4Health 02/2023-01/2027European Union Horizon 2020 project MOOD 874850European Union Horizon RIA 2023 project LEAPS 101094685European Union's Horizon 2020 Research and Innovation Programme 725422-ReservoirDOCSFonds National de la Recherche Scientifique F.4515.22Foundation for Science and Technology UIDB/50026/2020Foundation for Science and Technology UIDP/50026/2020KU Leuven C14/18/094NIAID NIH HHS R01 AI153044NIAID NIH HHS R01 AI162611NIAID NIH HHS U19 AI135995NIH HHS R01 AI153044NIH HHS R01 AI162611NIH HHS U19 AI135995Research Foundation - Flanders G098321NWellcome TrustWellcome Trust 06298/Z/17/Z
6 · The paper itself

Abstract

The dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission are influenced by a variety of factors, including social restrictions and the emergence of distinct variants. In this study, we delve into the origins and dissemination of the Alpha, Delta, and Omicron-BA.1 variants of concern in Galicia, northwest Spain. For this, we leveraged genomic data collected by the EPICOVIGAL Consortium and from the GISAID database, along with mobility information from other Spanish regions and foreign countries. Our analysis indicates that initial introductions during the Alpha phase were predominantly from other Spanish regions and France. However, as the pandemic progressed, introductions from Portugal and the United States became increasingly significant. The number of detected introductions varied from 96 and 101 for Alpha and Delta to 39 for Omicron-BA.1. Most of these introductions left a low number of descendants (<10), suggesting a limited impact on the evolution of the pandemic in Galicia. Notably, Galicia's major coastal cities emerged as critical hubs for viral transmission, highlighting their role in sustaining and spreading the virus. This research emphasizes the critical role of regional connectivity in the spread of SARS-CoV-2 and offers essential insights for enhancing public health strategies and surveillance measures.

Indexed as

COVID-19SARS-CoV-2Genome, ViralHumansPandemicsPhylogenySpaindispersalphylogeographySARS‐CoV‐2variants of concern

Identifiers

PMID38940448
PMCPMC11742125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.